Accelerating your Business Strategy
World Class Operator
•Proven Leader with 27 years of direct pharma/cell therapy experience
•GMP & Quality expertise across clinical and commercial manufacturing
•Process Development and Supply Chain experience in small, large molecules (DS & DP) •Multiple manufacturing platforms
•Direct CDMO Program/Business Management & Strategy
Technical Expertise
•Expertise using closed and automated manufacturing process platforms
•Expertise using specialized instruments and equipment specific to cell therapy
•Expertise in a variety of cell types CAR T, T cells, NK cells, cancer cell lines, HSCs, iPSCs, MSCs
•Plasmid and mRNA Development and Manufacturing
•Product Development and Launch (CDMO services)
Strategy & Execution
•Full-service CDMO enablement (All modalities)
•Designed, Built and Qualified two (2) Cell therapy facilities (East and West Coasts)
•Strategy Operations Planning our Proprietary Software CellSuite (www.CellSuite.app)
•Competitive Landscape Assessments
•Forecasting (Financial & Capacity)
•Organizational Design
•Workforce Planning and Modeling (Production Schedules, Labor, Risks)
Biotech & CDMO Consulting
Our biotech & CDMO consulting services provide expert guidance and support to biotech companies and organizations, helping them navigate the complex landscape of biotech innovation.
Background
Dan Garcia Founder & CEO
With over 27 years of executive leadership in Innovator Biotech & CDMOs, Dan Garcia is a seasoned operator who has built and scaled successful Biologics and cell therapy CDMOs from startup through profitability.
As Founder and CEO of Cell Therapy Ready, he leverages deep expertise across cell & gene therapy, large and small molecule development, manufacturing, planning and testing. His track record includes full-cycle facility design, build, commissioning, strategic growth, talent acquisition, and operational execution that consistently delivers both top- and bottom-line results.
Prior to founding Cell Therapy Ready, Dan served as General Manager at Thermo Fisher Scientific, where he led the Cell Therapy CDMO Services Business Unit. He previously held strategic business and program management roles at Patheon Biologics.
His foundational experience came from 17 years at Amgen, where he held progressive leadership positions in contract manufacturing, operations planning, and clinical/commercial operations.
Dan holds an MBA from Pepperdine University and a BS in Biochemistry from California Polytechnic State University (Cal Poly).
Passionate about advancing life-changing cell and gene therapies, Dan is dedicated to building high-performing teams and delivering operational excellence that brings innovative treatments to patients faster.
GMP Facilities - Plasmids, mRNA, Viral Vectors, Cell Therapy, Biologics and Small Molecules
Design, Build and Qualification of state-of-the-art facilities with working expertise in the operational readiness of all modalities. Experienced leader producing high-quality biologics and cell therapies at scale, helping to bring innovative treatments to market faster.
Productivity Enablement - Forecasting and Workforce Planning
Our bioinformatics expertise and software tools enable us to analyze and interpret complex biological data, providing insights into financial forecast and capacity modeling